“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
“RNA knows the diagnostics space. From Nanosphere to Biocartis, RNA has been my valuation firm of choice. They are responsive, efficient and I know that they’ll deliver. I’ve been glad to see their success and growth. It’s well deserved.”
“The RNA team has helped us with tax and financial reporting-oriented valuation work. Its nice to work with a firm that not only understands the intricacies of reporting requirements but actually understands the drug development business.”
“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”
Enter your email address below to receive updates from RNA Advisors.